Brooks Lab.

{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "60.02",
    "chg": -2.93,
    "chgp": "-4.65%",
    "dir": -1,
    "prev_price": "62.95",
    "mcapval": "181.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE650L01011",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "06:49 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "14.94 k",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-4130007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4130007.png",
        "date": "2026-07-31 10:11:38",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Lower Circuit With 4.52% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4119304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4119304.png",
        "date": "2026-07-24 11:00:10",
        "description": "At Rs 63.00, Brooks Laboratories Ltd found itself trapped at its lower circuit on 24 Jul 2026, with a 4.52% decline marking the maximum loss permitted by the 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a frozen price and unfilled sell orders throughout the session."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-4108920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4108920.png",
        "date": "2026-07-20 10:10:58",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Upgraded to Sell on Improved Valuation and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-upgraded-to-sell-on-improved-valuation-and-financial-metrics-4094547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4094547.png",
        "date": "2026-07-09 08:08:18",
        "description": "Brooks Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 July 2026, driven primarily by a significant improvement in its valuation metrics. Despite persistent challenges in financial performance and technical indicators, the company’s valuation grade has shifted from fair to very attractive, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Brooks Laboratories Ltd Valuation Shifts to Very Attractive Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-valuation-shifts-to-very-attractive-amid-market-challenges-4094210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_valuationdot_4094210.png",
        "date": "2026-07-09 08:00:30",
        "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both its historical averages and peer group valuations."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Lower Circuit With 4.81% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4093845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4093845.png",
        "date": "2026-07-08 15:00:14",
        "description": "At Rs 69.52, Brooks Laboratories Ltd found itself locked at its lower circuit limit of 4.81% on 08 Jul 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply at the floor price."
      },
      {
        "title": "Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4092481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_stocks_hitting_lower_circuit_4092481.png",
        "date": "2026-07-07 14:00:08",
        "description": "At Rs 73.03, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 7 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Brooks Laboratories Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-downgraded-to-strong-sell-amid-valuation-and-financial-concerns-4091651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BrooksLaborator_mojoScore_4091651.png",
        "date": "2026-07-07 08:19:18",
        "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 6 July 2026. The revision reflects a deterioration in valuation metrics, financial trends, and technical indicators, despite some pockets of fair valuation and moderate profitability. This comprehensive analysis explores the four key parameters that triggered the rating change and what it means for investors."
      },
      {
        "title": "Brooks Laboratories Gains 11.09%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-gains-1109-5-key-factors-driving-the-weeks-rally-4089054",
        "imagepath": "",
        "date": "2026-07-04 17:05:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Stock hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>30 Jun:</strong> Upgraded to Sell rating on improved valuation metrics</p>\n                    <p><strong>1 Jul:</strong> Hits upper circuit with 5.0% gain</p>\n                    <p><strong>2 Jul:</strong> Hits upper circuit again, gaining 4.99%</p>\n                    <p><strong>3 Jul:</strong> Week closes at ₹77.71, up 11.09%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹69.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-..."
      }
    ],
    "total": 339,
    "sid": "539063",
    "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Jul-2026",
      "details": "Appointment of Mr. Rajesh Mahajan as President - Trading.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "16-Jul-2026",
      "details": "We hereby inform that further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Brooks Steriscience Limited.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended 30th June 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Brooks Laboratories Ltd is Rated Sell

2026-07-31 10:11:38

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Brooks Laboratories Ltd Locks at Lower Circuit With 4.52% Loss — Sellers Queue, No Buyers in Sight

2026-07-24 11:00:10

At Rs 63.00, Brooks Laboratories Ltd found itself trapped at its lower circuit on 24 Jul 2026, with a 4.52% decline marking the maximum loss permitted by the 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a frozen price and unfilled sell orders throughout the session.

Read full news article

Brooks Laboratories Ltd is Rated Sell

2026-07-20 10:10:58

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Brooks Laboratories Ltd Upgraded to Sell on Improved Valuation and Financial Metrics

2026-07-09 08:08:18

Brooks Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 8 July 2026, driven primarily by a significant improvement in its valuation metrics. Despite persistent challenges in financial performance and technical indicators, the company’s valuation grade has shifted from fair to very attractive, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Brooks Laboratories Ltd Valuation Shifts to Very Attractive Amid Market Challenges

2026-07-09 08:00:30

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a fair to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points compared to both its historical averages and peer group valuations.

Read full news article

Brooks Laboratories Ltd Locks at Lower Circuit With 4.81% Loss — Sellers Queue, No Buyers in Sight

2026-07-08 15:00:14

At Rs 69.52, Brooks Laboratories Ltd found itself locked at its lower circuit limit of 4.81% on 08 Jul 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply at the floor price.

Read full news article

Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session

2026-07-07 14:00:08

At Rs 73.03, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 7 Jul 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Brooks Laboratories Ltd Downgraded to Strong Sell Amid Valuation and Financial Concerns

2026-07-07 08:19:18

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 6 July 2026. The revision reflects a deterioration in valuation metrics, financial trends, and technical indicators, despite some pockets of fair valuation and moderate profitability. This comprehensive analysis explores the four key parameters that triggered the rating change and what it means for investors.

Read full news article

Brooks Laboratories Gains 11.09%: 5 Key Factors Driving the Week’s Rally

2026-07-04 17:05:56

Key Events This Week

29 Jun: Stock hits lower circuit amid heavy selling pressure

30 Jun: Upgraded to Sell rating on improved valuation metrics

1 Jul: Hits upper circuit with 5.0% gain

2 Jul: Hits upper circuit again, gaining 4.99%

3 Jul: Week closes at ₹77.71, up 11.09%

Week Open

₹69.95

Read full news article

View All News